Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 174   

Articles published

GSK 1,415.50 +3.50 (0.25%)
price chart
Most Volatile Stocks: EMC Corporation (NYSE:EMC), GlaxoSmithKline plc ...
EMC Corporation (NYSE:EMC), Cisco, and VCE declared on Wednesday that the next phase of evolution for VCE. Anticipated to be finalized this quarter, VCE will become an EMC business.
Related articles »  
GSK Beats On Earnings; Share Buyback And Spin-off Compensate For ...
GlaxoSmithKline plc (ADR) (GSK) released third quarter (3Q) results for fiscal year 2014 (FY14) before market opened today.
Beat The FTSE 100 With SABMiller plc, GlaxoSmithKline plc And British ...
With the FTSE 100 having fallen by over 8% during the last month, beating the returns on the index has become a priority for a number of UK investors.
Related articles »  
GlaxoSmithKline plc (ADR) Declares Quarterly Dividend of $0.61 (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) announced a quarterly dividend on Thursday, October 23rd, Analyst Ratings News reports.
GlaxoSmithKline plc's "Underperform" Rating Reiterated at Credit Suisse (GSK)
GlaxoSmithKline plc (NYSE:GSK)'s stock had its �underperform� rating reiterated by equities researchers at Credit Suisse in a research report issued on Thursday.
A Blue-Chip Starter Portfolio: GlaxoSmithKline plc, BHP Billiton plc And Rolls ...
Every quarter I take a look at the largest FTSE 100 companies in each of the index's 10 industries to see how they shape up as a potential 'starter' portfolio.
Related articles »  
Can GlaxoSmithKline plc Help You To Retire Rich?
It's been a very tough year for investors in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US). Shares in the pharmaceutical company have fallen by 10% over the last year and have shown little sign of improving their performance in recent weeks.
GlaxoSmithKline plc Given Consensus Rating of "Hold" by Brokerages ...  Ticker Report
Related articles »  
What This Top Dividend Portfolio Is Holding Now: HSBC Holdings plc ...
GlaxoSmithKline is in the midst of a bribery scandal. It isn't the first company to face this kind of situation, and it won't be the last.
Related articles »  
3 Reasons Why GlaxoSmithKline plc Could Be Ripe For Takeover
Life as an investor in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is tough at the moment. That's because shares in the pharmaceutical major have fallen by 10% in the last three months alone.
GlaxoSmithKline plc's Hold Rating Reaffirmed at Deutsche Bank (GSK)  WKRB News
Deutsche Bank Reiterates "Hold" Rating for GlaxoSmithKline plc (GSK)  Ticker Report
Related articles »  
5 Stunning Reasons Why GlaxoSmithKline plc And AstraZeneca plc Could ...
While investors in AstraZeneca (LSE: AZN) have experienced a very strong 2014 thus far, with shares in the pharmaceutical major gaining 27%, it's been a very different story for their counterparts in GlaxoSmithKline (LSE: GSK). Indeed, the latter has ...